Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A V MacKay

Showing results (21-30 of 45) with videos related to

Pageof 5
Sort By:
Acta Psychiatrica Scandinavica|September 1, 1990
Neuroleptic malignant syndrome (NMS) on neuroleptic withdrawalF M Corrigan, F Coulter, A V Mackay
British Journal of Clinical Pharmacology|March 29, 2012
The relationship of plasma chlorpromazine to its 7-hydroxy and sulphoxide metabolites in a large population of chronic schizophrenicsA V Mackay, A F Healey, J Baker
British Medical Journal|April 10, 1976
Labour on lithiumA V MacKay, R Loose, A I Glen
Journal of Neurochemistry|August 1, 1974
Minimum duration of trans-synaptic stimulation required for the induction of tyrosine hydroxylase by reserpine in the rat superior cervical ganglionR E Zigmond, A V Mackay, L L Iversen
Nature|August 3, 1978
Use of ADTN to define specific 3H-spirerone binding to receptors in brainM Quik, L L Iversen, A Larder, et al.
Journal of the Neurological Sciences|November 1, 1979
Alterations in [3H]spiperone binding in human caudate nucleus, substantia nigra and frontal cortex in the Shy-Drager syndrome and Parkinson's diseaseM Quik, E G Spokes, A V Mackay, et al.
Journal of Neurochemistry|April 1, 1978
Regional distribution of enzymes associated with neurotransmission by monoamines, acetylcholine and GABA in the human brainA V Mackay, P Davies, A J Dewar, et al.
The New England Journal of Medicine|March 1, 1979
Reduction of angiotensin-converting enzyme in substantia nigra in early-onset schizophreniaA Arregui, A V MacKay, L L Iversen, et al.
Psychological Medicine|May 1, 1980
Reduced activity of angiotensin-converting enzyme in basal ganglia in early onset schizophreniaA Arregui, A V Mackay, E G Spokes, et al.
Neuroscience|July 1, 1982
Human platelet monoamine oxidase--a useful enzyme in the study of psychiatric disorders?C J Fowler, K F Tipton, A V MacKay, et al.
Pageof 5

Showing results (21-30 of 45) with videos related to

Sort By:
Pageof 5
Acta Psychiatrica Scandinavica|September 1, 1990
Neuroleptic malignant syndrome (NMS) on neuroleptic withdrawalF M Corrigan, F Coulter, A V Mackay
British Journal of Clinical Pharmacology|March 29, 2012
The relationship of plasma chlorpromazine to its 7-hydroxy and sulphoxide metabolites in a large population of chronic schizophrenicsA V Mackay, A F Healey, J Baker
British Medical Journal|April 10, 1976
Labour on lithiumA V MacKay, R Loose, A I Glen
Journal of Neurochemistry|August 1, 1974
Minimum duration of trans-synaptic stimulation required for the induction of tyrosine hydroxylase by reserpine in the rat superior cervical ganglionR E Zigmond, A V Mackay, L L Iversen
Nature|August 3, 1978
Use of ADTN to define specific 3H-spirerone binding to receptors in brainM Quik, L L Iversen, A Larder, et al.
Journal of the Neurological Sciences|November 1, 1979
Alterations in [3H]spiperone binding in human caudate nucleus, substantia nigra and frontal cortex in the Shy-Drager syndrome and Parkinson's diseaseM Quik, E G Spokes, A V Mackay, et al.
Journal of Neurochemistry|April 1, 1978
Regional distribution of enzymes associated with neurotransmission by monoamines, acetylcholine and GABA in the human brainA V Mackay, P Davies, A J Dewar, et al.
The New England Journal of Medicine|March 1, 1979
Reduction of angiotensin-converting enzyme in substantia nigra in early-onset schizophreniaA Arregui, A V MacKay, L L Iversen, et al.
Psychological Medicine|May 1, 1980
Reduced activity of angiotensin-converting enzyme in basal ganglia in early onset schizophreniaA Arregui, A V Mackay, E G Spokes, et al.
Neuroscience|July 1, 1982
Human platelet monoamine oxidase--a useful enzyme in the study of psychiatric disorders?C J Fowler, K F Tipton, A V MacKay, et al.
Pageof 5